NetTargets and Cellkey sign MoU to collaborate on biomarker discovery

NetTargets has partnered with Cellkey, which provides a cutting-edge AI-based glycopeptide analysis platform, to discover biomarkers for early detection and treatment of cancer.

NetTargets presented at BIO KOREA 2023.

Je-Hoon Song, CITO of NetTargets, delivered a presentation titled "Discovery of Mechanism-based Drug Targets through the Integration of Artificial Intelligence and Systems Biology" at the BIO KOREA 2023 on May 11th, 2023.

11 May 2023

NetTargets has been selected as the Most Innovative Drug Discovery Company in East Asia at the Global Health and Pharma Biotechnology Awards 2023.

We are delighted to announce that NetTargets has been named the Most Innovative Drug Discovery Company in East Asia at the Global Health and Pharma Biotechnology Awards 2023.

08 May 2023

NetTargets will deliver a presentation at BIO KOREA 2023.

NetTargets will deliver a presentation at BIO KOREA 2023, to be held on 10-12 May at COEX, SEOUL (Presentation Schedule: May 11, 2023, 10:40 AM (KST)). It will also participate in partnering meetings and exhibit at the booth (no. Q25) during the conference.

21 Apr 2023

Comming soon

Our next news and events are coming soon

BACK TO THE LIST